5 assets in Kidney Benign Neoplasm

Therapeutic assets addressing Kidney Benign Neoplasm, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Lidocaine Kidney Benign Neoplasm	Hans Bahlmann	P3	B (60)
Marcaine Kidney Benign Neoplasm	Hans Bahlmann	P3	B (60)
Nepenthe Kidney Benign Neoplasm	Hans Bahlmann	P3	B (60)
Urea Kidney Benign Neoplasm	Zhen Wang, MD	P2	CCC (53)
Pyruvate Kidney Benign Neoplasm	Zhen Wang, MD	P2	CCC (52)